BioCrine

Business Data, Corporate Office and Headquarter Address

About

BioCrine is Drug Discovery in Sweden that focus on developer business. They cover business area such as developer, pharmaceutical innovation, diabetes, new concept, treatment, continual delivery, novel drug.

Business Type

Drug Discovery

Country

Sweden

Founded

-

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

Sveavägen 166
Box 3073
169 03 Solna
Sweden

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerpharmaceutical innovationdiabetesnew concepttreatmentcontinual deliverynovel drug

* We use standard office opening hours in near BioCrine's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

BioCrine Frequently Asked Questions

What or who is BioCrine?

BioCrine is Drug Discovery business from Sweden that founded in - ( years old in ), BioCrine business is focusing on Developer.

Where is BioCrine headquarter and corporate office address?

BioCrine headquarter office and corporate office address is located in Sveavägen 166 Box 3073 169 03 Solna Sweden.

Where is BioCrine country origins?

BioCrine was founded in Sweden.

What is Developer business focus on?

In , BioCrine is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with BioCrine, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.